InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Avoid the tax shock in licensing agreements


Christopher M Neumeyer reviews the lessons to be learned from two recent cases where Taiwan companies were ordered to pay taxes on licensing fees paid to a foreign licensor

In November 2016, a US district Court ordered a Taiwan company to pay taxes on licensing fees that it paid to a foreign licensor, despite the fact that such taxes are typically the licensor's obligation (Mondis Technology Ltd v Wistron...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

"Call it something with the word Virgin" maybe??? https://t.co/X7J2iiMYtZ

Mar 29 2017 04:57 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @HouseJudiciary: ✅ #BREAKING: @HouseJudiciary approves #HR1695- Register of Copyrights Selection & Accountability Act. 1st step to moder…

Mar 29 2017 04:37 ·  reply ·  retweet ·  favourite
ManagingIP profile

SCOTUS revisits patent venue in TC Heartland v Kraft arguments - analysis https://t.co/u8u7RmhQ7J https://t.co/bqESUSa7Vq

Mar 29 2017 04:36 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


March 2017

Roundtable: The second medical use challenge – full transcript

Three leading patent specialists discussed one of the most challenging issues in IP at the moment – incentivising new uses for known drugs – at a recent roundtable discussion. The participants were: Jurgen Dressel, head of global patent litigation strategy, Novartis Pharma; Galit Gonen, VP and general counsel for Europe at Teva; and Professor Sir Robin Jacob, former Court of Appeal judge and professor at the Institute of Brand and Innovation Law, University College London



Most read articles

Supplements